These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 7793878)
1. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Brötz H; Bierbaum G; Markus A; Molitor E; Sahl HG Antimicrob Agents Chemother; 1995 Mar; 39(3):714-9. PubMed ID: 7793878 [TBL] [Abstract][Full Text] [Related]
2. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Brötz H; Bierbaum G; Reynolds PE; Sahl HG Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483 [TBL] [Abstract][Full Text] [Related]
3. Effects of the lantibiotic mersacidin on the morphology of staphylococci. Molitor E; Kluczny C; Brötz H; Bierbaum G; Jack R; Sahl HG Zentralbl Bakteriol; 1996 Jul; 284(2-3):318-28. PubMed ID: 8837393 [TBL] [Abstract][Full Text] [Related]
4. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus. Sass P; Jansen A; Szekat C; Sass V; Sahl HG; Bierbaum G BMC Microbiol; 2008 Oct; 8():186. PubMed ID: 18947397 [TBL] [Abstract][Full Text] [Related]
5. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Brötz H; Bierbaum G; Leopold K; Reynolds PE; Sahl HG Antimicrob Agents Chemother; 1998 Jan; 42(1):154-60. PubMed ID: 9449277 [TBL] [Abstract][Full Text] [Related]
6. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis. Singh M; Chang J; Coffman L; Kim SJ J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603 [TBL] [Abstract][Full Text] [Related]
7. Cloning, sequencing and production of the lantibiotic mersacidin. Bierbaum G; Brötz H; Koller KP; Sahl HG FEMS Microbiol Lett; 1995 Mar; 127(1-2):121-6. PubMed ID: 7737474 [TBL] [Abstract][Full Text] [Related]
8. Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus. Maki H; Miura K; Yamano Y Antimicrob Agents Chemother; 2001 Jun; 45(6):1823-7. PubMed ID: 11353632 [TBL] [Abstract][Full Text] [Related]
9. Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin. Szekat C; Jack RW; Skutlarek D; Färber H; Bierbaum G Appl Environ Microbiol; 2003 Jul; 69(7):3777-83. PubMed ID: 12839744 [TBL] [Abstract][Full Text] [Related]
10. The lantibiotic mersacidin is an autoinducing peptide. Schmitz S; Hoffmann A; Szekat C; Rudd B; Bierbaum G Appl Environ Microbiol; 2006 Nov; 72(11):7270-7. PubMed ID: 16980420 [TBL] [Abstract][Full Text] [Related]
11. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. Billot-Klein D; Gutmann L; Bryant D; Bell D; Van Heijenoort J; Grewal J; Shlaes DM J Bacteriol; 1996 Aug; 178(15):4696-703. PubMed ID: 8755902 [TBL] [Abstract][Full Text] [Related]
12. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847 [TBL] [Abstract][Full Text] [Related]
13. Heterologous Expression of Mersacidin in Viel JH; Jaarsma AH; Kuipers OP ACS Synth Biol; 2021 Mar; 10(3):600-608. PubMed ID: 33689311 [TBL] [Abstract][Full Text] [Related]
14. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849 [TBL] [Abstract][Full Text] [Related]
15. New insights into the mode of action of the lantibiotic salivaricin B. Barbour A; Tagg J; Abou-Zied OK; Philip K Sci Rep; 2016 Aug; 6():31749. PubMed ID: 27526944 [TBL] [Abstract][Full Text] [Related]
16. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus. Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049 [TBL] [Abstract][Full Text] [Related]
17. Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation. Knerr PJ; Oman TJ; Garcia De Gonzalo CV; Lupoli TJ; Walker S; van der Donk WA ACS Chem Biol; 2012 Nov; 7(11):1791-5. PubMed ID: 22920239 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial mechanism of lantibiotics. Islam MR; Nagao J; Zendo T; Sonomoto K Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511 [TBL] [Abstract][Full Text] [Related]
19. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Brötz H; Josten M; Wiedemann I; Schneider U; Götz F; Bierbaum G; Sahl HG Mol Microbiol; 1998 Oct; 30(2):317-27. PubMed ID: 9791177 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria. Ruzin A; Singh G; Severin A; Yang Y; Dushin RG; Sutherland AG; Minnick A; Greenstein M; May MK; Shlaes DM; Bradford PA Antimicrob Agents Chemother; 2004 Mar; 48(3):728-38. PubMed ID: 14982757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]